Clinical Trial Update: PTHrP and Osteoporosis [Phase 2]

View source ↗

Summary

This document reports on the completed Phase 2 clinical trial evaluating parathyroid hormone-related peptide (PTHrP) for osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• PTHrP (parathyroid hormone-related peptide)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Osteoporosis | Phase 2 | Status: COMPLETED